Baker Bros. Advisors »

Mural Oncology shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Mural Oncology (MURA) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Mural Oncology

Tip: Access up to 7 years of quarterly data

All positions including Mural Oncology held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mural Oncology by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 223k 4.89

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Rhythm Pharmaceuticals (RYTM)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Abcellera Biologics (ABCL)
Bicycle Therapeutics Sponsored Ads (BCYC)
Edgewise Therapeutics (EWTX)
Immunocore Holdings Ads (IMCR)
Kodiak Sciences (KOD)
Roivant Sciences SHS (ROIV)
Replimune Group (REPL)
Denali Therapeutics (DNLI)

View all positions for Baker Bros. Advisors

Top funds holding Mural Oncology

Armistice Capital
Westfield Capital Management Company
BlackRock
Vanguard Group
Verition Fund Management
Solas Capital Management
Alta Fundamental Advisers
Newtyn Management
Prosight Management
Geode Capital Management
PRIMECAP Management Company
Baker Bros. Advisors
Sonic GP
Nuveen Asset Management
Squarepoint Ops

View all funds holding Mural Oncology